ELLEN EKUASE: Open Payments
NPI 1316200132 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 16 payments from 7 companies in 2025. Trend: 2023 $117 · 2024 $239 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $152 |
| PROTEGA PHARMACEUTIALS INC | 3 | $46 |
| Lilly USA, LLC | 2 | $39 |
| Hologic Sales and Service, LLC | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Dexcom G6 Transmitter, ROXYBOND, MOUNJARO, PREVNAR 20, THIRD WAVE, Ozempic, APTIMA.
Industry payments across MO — which companies pay providers there.
